Your browser doesn't support javascript.
loading
Surgery for cerebral cavernous malformations: a systematic review and meta-analysis.
Harris, Lauren; Poorthuis, Michiel H F; Grover, Patrick; Kitchen, Neil; Al-Shahi Salman, Rustam.
Afiliación
  • Harris L; Department of Neurosurgery, National Hospital for Neurology and Neurosurgery, Queen Square, London, UK. lauren.harris7@nhs.net.
  • Poorthuis MHF; Department of Neurology and Neurosurgery, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, Netherlands.
  • Grover P; Department of Neurosurgery, National Hospital for Neurology and Neurosurgery, Queen Square, London, UK.
  • Kitchen N; Department of Neurosurgery, National Hospital for Neurology and Neurosurgery, Queen Square, London, UK.
  • Al-Shahi Salman R; Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK. Rustam.al-shahi@ed.ac.uk.
Neurosurg Rev ; 45(1): 231-241, 2022 Feb.
Article en En | MEDLINE | ID: mdl-34191202
ABSTRACT

BACKGROUND:

We sought to quantify the risks of neurosurgical excision of cerebral cavernous malformations (CCMs) in a systematic review of cohort studies.

METHODS:

We updated our previous systematic review by searching OVID Medline, OVID EMBASE, and the Cochrane Library from 1 January 2013 to 30 April 2019. The primary outcome was a composite of death attributed to CCM or surgery, non-fatal symptomatic intracerebral haemorrhage (ICH), or new or worsened persistent non-haemorrhagic focal neurological deficit (FND).

RESULTS:

We included 70 cohorts, 67 reporting surgery alone, and three compared surgery to conservative management. A total of 5,089 patients (median age 36 years, 52% female) underwent surgery (total follow-up 19,404 patient-years). The annual rate of the composite outcome was 4.2% (95% CI 2.9 to 5.7; 46 cohorts; I2 = 93%), which was higher in cohorts reporting exclusively brainstem CCM (6.0%, 95% CI 4.1-8.3; 25 cohorts, I2 = 92%) versus predominantly supratentorial CCM (2.4%, 95% CI 1.3-3.8, 21 cohorts, I2 = 86%, phet = 0.001). The annual rate of the composite outcome was higher in cohorts with > 95% presenting with ICH (6.1%, 95% CI 4.2-8.4; 23 cohorts, I2 = 93%) versus others (2.3%, 95% CI 1.2-3.7; 23 cohorts, I2 = 83%, phet = 0.001). The incidence of the composite outcome did not change over time in cohorts of exclusively brainstem CCM (p = 0.7) or predominantly supratentorial CCM (p = 0.5).

CONCLUSIONS:

The risk of death, ICH, or FND after CCM excision is ~ 4%. This risk is higher for brainstem CCM and CCM that have caused ICH but has not changed over time. TRIAL REGISTRATION This systematic review was registered (PROSPERO CRD42019131246).
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hemangioma Cavernoso del Sistema Nervioso Central Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies / Systematic_reviews Límite: Adult / Female / Humans / Male Idioma: En Revista: Neurosurg Rev Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hemangioma Cavernoso del Sistema Nervioso Central Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies / Systematic_reviews Límite: Adult / Female / Humans / Male Idioma: En Revista: Neurosurg Rev Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido